Argent BioPharma Limited

RGT.L · LSE
Analyze with AI
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Activities
Net Income£0£0£0£0
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0£0£0
Stock-Based Comp.£0£0£0£0
Change in WC£0£0£0£0
Other Non-Cash-£8£0£0£0
Operating Cash Flow-£8£0£0£0
Investing Activities
PP&E Inv.-£0-£0-£3-£3
Net Acquisitions£0£0-£0-£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.£0£1£2£2
Investing Cash Flow-£0£1-£1-£1
Financing Activities
Debt Repay.£0£7£0£6
Stock Issued£16£3£11£13
Stock Repurch.£0-£0-£1-£1
Dividends Paid£0£0£0£0
Other Fin. Act.-£7-£0-£0-£0
Financing Cash Flow£8£10£10£17
Forex Effect-£0£0-£0-£0
Net Chg. in Cash£0-£2-£4£4
Supplemental Information
Beg. Cash£0£2£5£2
End Cash£1£0£2£5
Free Cash Flow-£14-£12-£15-£15
Argent BioPharma Limited (RGT.L) Financial Statements & Key Stats | AlphaPilot